Artigo Revisado por pares

Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma

2018; Nature Portfolio; Volume: 24; Issue: 11 Linguagem: Inglês

10.1038/s41591-018-0198-0

ISSN

1546-170X

Autores

Christian U. Blank, Elisa A. Rozeman, Lorenzo F. Fanchi, Karolina Sikorska, B. van de Wiel, Pia Kvistborg, Oscar Krijgsman, Marlous van den Braber, Daisy Philips, Annegien Broeks, Johannes V. van Thienen, Henk Mallo, S. Adriaansz, Sylvia ter Meulen, Loes M. Pronk, Lindsay G. Grijpink-Ongering, Annemarie Bruining, Rachel M. Gittelman, Sarah Warren, Harm van Tinteren, Daniel S. Peeper, John B.A.G. Haanen, Alexander C.J. van Akkooi, Ton N. Schumacher,

Tópico(s)

Immunotherapy and Immune Responses

Referência(s)
Altmetric
PlumX